Ana Carolina Covre Coan

🇧🇷👩🏻‍⚕️🩺⚕️| 5th year medical student at @ufesoficial | aspiring residence in the USA🇺🇸 | Step 1 pass

[Ana Carolina Covre Coan @AnaCCoan]

Hello, #MedTwitter
Halfway there, heart full of certainty: I'm exactly where I'm supposed to be. Excited for the next steps!🤞🏼⚕️

[Ana Carolina Covre Coan @AnaCCoan]

Lembranças da minha primeira viagem internacional para apresentar moderated poster no AHA em Chicago! 🫀🇺🇸

Experiência que só foi possível graças ao @metaacademy_ofc que vai muito além de ensinar metodologia científica: forma pesquisadores com mentalidade de excelência 🚀

[Ana Carolina Covre Coan @AnaCCoan]

full text: https://t.co/1I1a3iK4sr

[Ana Carolina Covre Coan @AnaCCoan]

Nossa meta-análise de 4 RCTs mostrou que a albumina reduziu mortalidade e melhorou desfechos em pacientes com encefalopatia hepática.
Muito feliz com essa publicação na @hepatologyforum!!
Agradecimento especial ao curso que me preparou para isso ser possível! @metaacademy_ofc

[Ana Carolina Covre Coan @AnaCCoan]

+1 do time 🚀

[Gabriel Scarpioni Barbosa @scarpionigab]

Our meta-analysis, presented at ACC.25 and now in the journal Heart, evaluates surgical ablation in non-mitral heart surgeries. We saw a reduction in postoperative atrial fibrillation, but an increase in pacemaker implantation rate. No difference in stroke or mortality.

[Ana Carolina Covre Coan @AnaCCoan]

Excited to announce that my first meta-analysis as first author has been accepted for publication in @hepatologyforum 🎉🎉

Thanks to all co-authors for the support!!

[Ana Carolina Covre Coan @AnaCCoan]

The awaited pass is finally here! The first step toward a big dream has been achieved 🇺🇸

I thank God and all the friends and family who stood by my side throughout this year of intense dedication 🙏🏼🙏🏼
#MedTwitter #USMLE #step1

[Ana Carolina Covre Coan @AnaCCoan]

+1 🙏🏼

[Alonzo Armani Prata @Alonzo_Prata]

🚨 New publication alert!

We conducted a meta-analysis of atrial shunt device therapy in HFpEF across 3 RCTs

🔎 Key findings:
❌ No improvement in MACE, QoL, MI, or stroke/TIA
⚠️ Trend toward ↑ HF events & CV mortality

➡️ Highlights the need for better patient selection

[Ana Carolina Covre Coan @AnaCCoan]

Last month I joined PAD for the 1st time as a plastic surgery student. A project by Ufes that for 33 years has brought dermatologic care and skin cancer prevention to communities across Espírito Santo. Surgical experience, lots learned and real impact. Amazing experience!

[Ana Carolina Covre Coan @AnaCCoan]

@Alonzo_Prata ❤️❤️

[Ana Carolina Covre Coan @AnaCCoan]

Hello, #MedTwitter
Halfway there, heart full of certainty: I'm exactly where I'm supposed to be. Excited for the next steps!🤞🏼⚕️

[Pedro Gabriel Scardini @pedroscardini]

🚨 Exciting news! Our meta-analysis on SGLT2i in MI patients has been accepted for publication in Cardiovascular Diabetology!

🔎 Key findings:
✅ SGLT2i reduced MACE events & heart failure hospitalizations
✅ Supports broader use post-MI

Grateful to my co-authors & mentors!🙌

[Ana Carolina Covre Coan @AnaCCoan]

@Alonzo_Prata Parabénss! Fruto de muito esforço e dedicação ❤️🙏🏼

[Alonzo Armani Prata @Alonzo_Prata]

After a long period of hard work, got my Step 2 CK score—beyond thrilled! Now closer to my dream! 🇺🇸 🩺
#MedX #MedTwitter #USMLE #Step2 #Step2CK

[HeartRhythm @hrs_journal]

Cardioneuroablation in Patients with Vasovagal Syncope: An updated systematic review and meta-analysis

@Alonzo_Prata @erickatsuyama97 @christiankfuku, @pedroscardini @VanioAntunes @AnaCCoan

https://t.co/SjX2uZLHkq

[Pasquale Paolisso @P_Paolisso]

👥Systematic meta-analysis of 10 RCTs (>22,000 pts - 51.2% w/T2DM) to determine the impact of SGLT2i in pts w/ recent or previous MI.
🗓️Mean age 62 yrs; median FU was 21 months.

Main findings:
💥HF hospitalization rates were ⬇️in pts on SGLT2i compared with placebo (RR 0.77; 95% CI 0.69, 0.85; p<0.001).

💥These benefits of SGLT2i were consistent regardless of the timing of the last MI.

💥No statistically significant difference in all-cause mortality was observed between the groups (RR 0.88; 95% CI 0.78, 1.00; p=0.058).

Read more on #CardiovascularDiabetology @BioMedCentral 👇
https://t.co/dNKZ0xogjw

[Ana Carolina Covre Coan @AnaCCoan]

@h2h_research @ACCinTouch @metaacademy_ofc @RCardoso_MD 👏🏼👏🏼👏🏼👏🏼👏🏼👏🏼👏🏼

[Heart2Heart Research Group @h2h_research]

We are honored to announce Gabriel’s research has been accepted to present at the @ACCinTouch conference 2025!!🇺🇸
We couldn’t be more proud of this amazing team!🫀🌟
#ACC #CardioTwitter

A special thank you for the @metaacademy_ofc and Dr.@RCardoso_MD

[Heart2Heart Research Group @h2h_research]

Hello #MedTwitter!!

We are the Heart-2-Heart Research Group!🌟
We are made of ambitious med students and physicians from 🇧🇷
We aim to produce high-impact research in #Cardiology 🫀 with rigorous methodological standards.

Let’s connect #cardiotwitter!!🫀🫀

[Ana Carolina Covre Coan @AnaCCoan]

Hoje, participei de uma ação de rastreamento da retinopatia diabética, promovida pela Liga de Oftalmologia da UFES (LAOFES). A iniciativa envolveu diagnóstico e encaminhamento para tratamento, essencial para a qualidade de vida desses pacientes.👁️

[Ana Carolina Covre Coan @AnaCCoan]

@marques_julia_ 🥹💕💕💕

[Ana Carolina Covre Coan @AnaCCoan]

Very grateful for having found this dedicated group that is always teaching me! (Missing a few participants in the photo) 🤝🏼💕

[Meta Analysis Academy @metaacademy_ofc]

This Thanksgiving, let’s celebrate the friendships and connections that make the Meta Analysis Academy so special.

Share a memory or moment from the community that you’re grateful for. Let’s honor the spirit of gratitude together!